Business Services Industry

Incyte to Present at the 26th Annual JPMorgan Healthcare Conference

Business Wire, Jan 2, 2008

WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) announced today it will present at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008 at 9:30 a.m. (Pacific Time) / 12:30 p.m. (Eastern Time).

Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and discuss its most advanced drug discovery and development programs.

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for HIV, diabetes, oncology and inflammation. For additional information on Incyte, visit the Company's web site at www.incyte.com.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale